THE AMERICAN SOCIETY FOR CELL BIOLOGY
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$7,068,106
Program Services
66%
Government Grants
12%
Contributions
12%
Other
6%
Investments
4%
Fundraising Events
0%
Membership Dues
0%
Expenses in 2024
$6,614,974
Salaries & Benefits
44%
Other
24%
Fees to Service Providers
19%
Offices, Occupancy & IT
9%
Advertising & Promotion
2%
Grants
1%
Depreciation
<1%
Interest
<1%
Benefits to Members
0%
Revenues
2023
2024
Change
Contributions
$1,691,126
$814,126
-52%
Government Grants
$1,273,082
$870,513
-32%
Fundraising Events
$0
$0
-
Program Services
$4,401,467
$4,664,266
+6%
Membership Dues
$0
$0
-
Investments
$274,285
$307,150
+12%
Other
$214,661
$412,051
+92%
Total Revenues
$7,854,621
$7,068,106
-10%
Expenses
2023
2024
Change
Grants
$205,882
$93,967
-54%
Benefits to Members
$0
$0
-
Salaries & Benefits
$3,016,018
$2,882,859
-4%
Fees to Service Providers
$1,846,168
$1,281,887
-31%
Advertising & Promotion
$130,607
$106,669
-18%
Offices, Occupancy & IT
$504,598
$598,853
+19%
Interest
$42,655
$14,780
-65%
Depreciation
$46,517
$30,276
-35%
Other
$1,831,250
$1,605,683
-12%
Total Expenses
$7,623,695
$6,614,974
-13%
Net income
2023
2024
Change
Net income
+$230,926
+$453,132
+96%
Functional Expenses
Summary
2023
2024
Change
Program
$5,294,325
$4,364,009
-18%
Admin
$2,328,829
$2,250,652
-3%
Fundraising
$541
$313
-42%
Total Expenses
$7,623,695
$6,614,974
-13%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)